Support our Foundation of Myology project
1722 news items
Identification of the causes of death of the only patient treated in the first CRISPR-Cas9 gene therapy trial for DMD
On 10/12/2023
American researchers have analysed the causes of death of a 27-year-old Duchenne muscular dystrophy (DMD) patient who took part in the first trial using the…
When a smartphone app reliably assesses peak cough flow
On 08/12/2023
A study carried out in Spain on 50 patients suffering from Charcot’s disease (n=26), autoimmune myasthenia (n=9) or genetic myopathy (n=15) shows that sound analysis…
Treatment of thymoma with immune checkpoint inhibitors increases the risk of muscle toxicity
On 07/12/2023
An analysis of various registries and clinical trial data, carried out by an international team involving researchers from the Institute of Myology, revealed: 1,495 cases…
Pre-injection aerobic exercise increases the effectiveness of gene therapy
On 07/12/2023
American researchers have investigated the benefits of a short, low-intensity physical activity session on the efficacy of gene therapy product transduction in mouse models of…
Scoliosis associated with early muscle weakness should prompt a search for CMS
On 06/12/2023
This is the conclusion of an article by a Turkish team which reviewed the records of eleven patients with congenital myasthenic syndrome presenting with scoliosis:…
GNE myopathy and 6′-sialyllactose: mixed results
On 06/12/2023
A South Korean team conducted a randomised trial of 6′-sialyllactose (6SL) versus placebo in GNE myopathy for almost two years (96 weeks) in 20 participants…
Painful muscle cramps at the forefront in a very rare form of hereditary sensory-motor neuropathy
On 05/12/2023
Okinawa-type neurogenic muscular atrophy (or HMSN-P) is an extremely rare hereditary neuropathy. Japanese researchers have taken a new interest in what is one of the…
DMD: first human study of DT-DEC01 cell therapy
On 04/12/2023
A Polish-American team working in collaboration with the laboratory Dystrogen Therapeutics has published the results of administering a new cell therapy product, DT-DEC01, to patients…
M&M’s – Muscle Monday Seminar – 11 December – Fabio Pinna (Italy)
On 04/12/2023
NAD+ metabolism in cancer- and chemotherapy-induced cachexia 11 December 2023 – from 12 to 1pm Fabio Pinna (Department of Clinical and Biological Sciences, University of Torino,…
DREAMS – a new Horizon Europe project brings hope to rare disease patients
On 29/11/2023
The objective of this 5-year project is to discover treatments for 5 rare neuromuscular disorders through a groundbreaking methodology combining Artificial intelligence (AI), stem cells…
Garetosmab is effective in fibrodysplasia ossificans progressiva
On 27/11/2023
The Phase II LUMINA 1 trial assessed the safety and efficacy of garetosmab, a monoclonal antibody that blocks activin A signaling pathways, in 44 adults…
Facial involvement is common in inclusion myositis
On 24/11/2023
Following on from previous work on facioscapulohumeral muscular dystrophy (FSHD), researchers in Marseilles have studied the characteristics of facial muscle deficit in people with inclusion…
ERN EURO-NMD webinar, 30th Nov. – Dr. Montserrat Olivé Plana (Spain)
On 23/11/2023
Myopathology in protein aggregate myopathies and vacuolar myopathies 30th November 2023 – 4pm Paris time Dr. Montserrat Olivé Plana (Hospital Santa Creu i Sant Pau,…
Testosterone in DMD improves the situation but does not normalise it
On 23/11/2023
The Newcastle team looked at the long-term follow-up of a cohort of 15 boys with Duchenne muscular dystrophy on corticosteroids who were treated with increasing…
A new glycogen overload myopathy
On 22/11/2023
French researchers report the discovery of a gene responsible for a new myopathy beginning in childhood and accompanied by an accumulation of glycogen in the…
The expertise of the NMR laboratory used to monitor the growth of a patient’s heart – Interview with Benjamin Marty
On 21/11/2023
Benjamin Marty is co-leader of the NMR and Spectroscopy Laboratory at the Institute’s Neuromuscular Investigation Center. Together with Yves Fromes, also a researcher in this…
Mariko Okubo awarded at the WMS for the discovery of a potential new role for lamins – Interview
On 21/11/2023
Mariko Okubo is a post-doctoral researcher in the Myology Centre for Research in the « Myomatrix & Myonucleus Related Diseases: Genetics & Pathophysiology » team.…
Biology of T cells in neuromuscular diseases: the case of DMD and ALS
On 21/11/2023
In neuromuscular diseases of different pathogenic origins, there is growing evidence of a close interaction between the immune system, the nerve and the muscle. The…
IV immunoglobulins are particularly effective against the cutaneous signs of dermatomyositis
On 20/11/2023
The good results of the international ProDERM trial, evaluating Octagam® intravenous immunoglobulin versus placebo in 95 adults with dermatomyositis, led to an extension of the…
A natural history of paediatric RYR1-related congenital myopathies
On 20/11/2023
Two major London paediatric neuromuscular centres carried out a retrospective study of 69 children with RYR1-related myopathy followed up between 1992 and 2019: 29 presented…
